The Investor Relations website contains information about Biogen's business for stockholders, potential investors, and financial analysts.
Biogen has announced an agreement to acquire RayThera Inc., a move set to significantly expand its immunology pipeline. This strategic acquisition enhances Biogen's research and development capabilities in a crucial therapeutic area, signaling potential growth. The deal…
Market Samachar is a news aggregator. This article was originally published by Biogen.com. Tap the button above to read the full story on their site.